CL - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 50/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

5/7 Elevated

5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)

0.32x

Defensive

Volatility (5Y p.a.)

19.1% p.a.

5-Year Horizon

Max Drawdown (5Y)

-31.1%

5-Year Horizon

Sharpe Ratio

0.03

Return / Risk

Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+12.9%
3 Years	19.7%	-31.1%	0.3	+8.3%
5 Years	19.1%	-31.1%	0.03	+3.1%
10 Years	20.0%	-31.1%	-0.03	+2%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 1388%.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

2 ISS Score: 2 / 10

Audit Risk

3 ISS Score: 3 / 10

Board Risk

5 ISS Score: 5 / 10

Short Ratio

4.23